Cargando…

Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Braadland, Peder R, Giskeødegård, Guro, Sandsmark, Elise, Bertilsson, Helena, Euceda, Leslie R, Hansen, Ailin F, Guldvik, Ingrid J, Selnæs, Kirsten M, Grytli, Helene H, Katz, Betina, Svindland, Aud, Bathen, Tone F, Eri, Lars M, Nygård, Ståle, Berge, Viktor, Taskén, Kristin A, Tessem, May-Britt
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2018
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877432/ https://www.ncbi.nlm.nih.gov/pubmed/29462127 http://dx.doi.org/10.1038/bjc.2017.470

Ejemplares similares

Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy
por: Braadland, Peder R, et al.
Publicado: (2017)

Proteomic analyses identify major vault protein as a prognostic biomarker for fatal prostate cancer
por: Ramberg, Håkon, et al.
Publicado: (2021)

Spermine and Citrate as Metabolic Biomarkers for Assessing Prostate Cancer Aggressiveness
por: Giskeødegård, Guro F., et al.
Publicado: (2013)

Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancer
por: Hansen, Ailin Falkmo, et al.
Publicado: (2016)

A novel non-canonical Wnt signature for prostate cancer aggressiveness
por: Sandsmark, Elise, et al.
Publicado: (2016)

Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia
por: Giskeødegård, Guro F, et al.
Publicado: (2015)

Metabolic Portraits of Breast Cancer by HR MAS MR Spectroscopy of Intact Tissue Samples
por: Haukaas, Tonje H., et al.
Publicado: (2017)

β-Adrenergic Receptor Signaling in Prostate Cancer
por: Braadland, Peder Rustøen, et al.
Publicado: (2015)

Integrative metabolic and transcriptomic profiling of prostate cancer tissue containing reactive stroma
por: Andersen, Maria K., et al.
Publicado: (2018)

Tissue Microstructure Is Linked to MRI Parameters and Metabolite Levels in Prostate Cancer
por: Selnæs, Kirsten Margrete, et al.
Publicado: (2016)

The Reproducibility of Deep Learning-Based Segmentation of the Prostate Gland and Zones on T2-Weighted MR Images
por: Sunoqrot, Mohammed R. S., et al.
Publicado: (2021)

SFRP4 gene expression is increased in aggressive prostate cancer
por: Sandsmark, Elise, et al.
Publicado: (2017)

The impact of pre-processing and disease characteristics on reproducibility of T2-weighted MRI radiomics features
por: Dewi, Dyah Ekashanti Octorina, et al.
Publicado: (2023)

Low β(2)-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism
por: Braadland, Peder Rustøen, et al.
Publicado: (2015)

Simultaneous (18)F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate Cancer
por: Esmaeili, Morteza, et al.
Publicado: (2018)

Spatial differentiation of metabolism in prostate cancer tissue by MALDI-TOF MSI
por: Andersen, Maria K., et al.
Publicado: (2021)

Simultaneous Detection of Zinc and Its Pathway Metabolites Using MALDI MS Imaging of Prostate Tissue
por: Andersen, Maria K., et al.
Publicado: (2020)

Low Blood Levels of LRG1 Before Radical Prostatectomy Identify Patients with High Risk of Progression to Castration-resistant Prostate Cancer
por: Guldvik, Ingrid Jenny, et al.
Publicado: (2022)

Gene signatures ESC, MYC and ERG-fusion are early markers of a potentially dangerous subtype of prostate cancer
por: Rye, Morten Beck, et al.
Publicado: (2014)

A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate Cancer
por: Tessem, May-Britt, et al.
Publicado: (2016)

Identification of metabolites from 2D (1)H-(13)C HSQC NMR using peak correlation plots
por: Öman, Tommy, et al.
Publicado: (2014)

Cholesterol synthesis pathway genes in prostate cancer are transcriptionally downregulated when tissue confounding is minimized
por: Rye, Morten Beck, et al.
Publicado: (2018)

Pseudo-T2 mapping for normalization of T2-weighted prostate MRI
por: Sørland, Kaia Ingerdatter, et al.
Publicado: (2022)

Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification
por: Guldvik, Ingrid J., et al.
Publicado: (2020)

The genes controlling normal function of citrate and spermine secretion are lost in aggressive prostate cancer and prostate model systems
por: Rye, Morten Beck, et al.
Publicado: (2022)

Exploring the diagnostic potential of adding T2 dependence in diffusion-weighted MR imaging of the prostate
por: Syversen, Ingrid Framås, et al.
Publicado: (2021)

Regulation of PBX3 expression by androgen and Let-7d in prostate cancer
por: Ramberg, Håkon, et al.
Publicado: (2011)

Association of β-Blocker Use at Time of Radical Prostatectomy With Rate of Treatment for Prostate Cancer Recurrence
por: Sivanesan, Shivanthe, et al.
Publicado: (2022)

Multiparametric Prostate MRI in Biopsy-Naïve Men: A Prospective Evaluation of Performance and Biopsy Strategies
por: Krüger-Stokke, Brage, et al.
Publicado: (2021)

A Quality Control System for Automated Prostate Segmentation on T2-Weighted MRI
por: Sunoqrot, Mohammed R. S., et al.
Publicado: (2020)

DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival
por: Pedersen, Christine Aaserød, et al.
Publicado: (2022)

Detection of Recurrent Prostate Cancer With (18)F-Fluciclovine PET/MRI
por: Selnæs, Kirsten Margrete, et al.
Publicado: (2020)

An optimized MALDI MSI protocol for spatial detection of tryptic peptides in fresh frozen prostate tissue
por: Høiem, Therese S., et al.
Publicado: (2022)

Serum Levels of Choline-Containing Compounds Are Associated with Aerobic Fitness Level: The HUNT-Study
por: Bye, Anja, et al.
Publicado: (2012)

Association of serum metabolome profile with the risk of breast cancer in participants of the HUNT2 study
por: Mrowiec, Katarzyna, et al.
Publicado: (2023)

Changes to Intermediary Metabolites in Sporadic and LRRK2 Parkinson's Disease Demonstrated by Proton Magnetic Resonance Spectroscopy
por: Aasly, Jan O., et al.
Publicado: (2015)

Metabolic characterization of triple negative breast cancer
por: Cao, Maria D, et al.
Publicado: (2014)

Effect of Delayed Centrifugation on the Levels of NMR-Measured Lipoproteins and Metabolites in Plasma and Serum Samples
por: Debik, Julia, et al.
Publicado: (2022)

Historical Biobanks in Breast Cancer Metabolomics— Challenges and Opportunities
por: Madssen, Torfinn S., et al.
Publicado: (2019)

Longitudinal Changes in Circulating Metabolites and Lipoproteins After Breast Cancer Treatment
por: Giskeødegård, Guro F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_60s37mmg4nk2tdbh948mqerfkf